Literature DB >> 8556520

Major antigenic region on the integrase (IN) protein of human immunodeficiency virus type 1 determined by reactivity of human sera and a monoclonal antibody to IN protein.

Y Tachibana1, A Yasuda, T Kurata, S Oka, K Shimada, A Kojima.   

Abstract

The gene encoding the integrase (IN) protein of human immunodeficiency virus type 1 (HIV-1) was expressed in vaccinia virus and Escherichia coli, and sera from 55 HIV-1-infected individuals were examined for immunoreactivity to the recombinant IN proteins by Western immunoblot. Approximately 98% (54 of 55) of the HIV-1-infected individuals showed reactivity to both the full-length IN protein of 32 kDa (IN32 protein) and the carboxy-terminal portion of the IN protein (IN17 protein). Serum samples from only 6 of the 54 antibody-positive individuals and a monoclonal antibody against the IN protein, 6F4, reacted with the amino-terminal portion of the IN protein (IN15 protein). The eight AIDS patients tested were seronegative to IN15 protein. The magnitude of reactivity to the recombinant IN proteins decreased slightly in the progression of the course of HIV-1 infection. These results suggest that a B-cell immunodominant epitope(s) on the IN protein is located on the C-terminal IN17 portion and that a minor epitope(s) recognizable by 6F4 and by rare patients is on the N-terminal IN15 portion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556520      PMCID: PMC368390          DOI: 10.1128/cdli.1.6.678-683.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  Standardized and simplified nomenclature for proteins common to all retroviruses.

Authors:  J Leis; D Baltimore; J M Bishop; J Coffin; E Fleissner; S P Goff; S Oroszlan; H Robinson; A M Skalka; H M Temin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

2.  Immunogenic nature of a Pol gene product of HTLV-III/LAV.

Authors:  J S Allan; J E Coligan; T H Lee; F Barin; P J Kanki; S M'Boup; M F McLane; J E Groopman; M Essex
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

3.  Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.

Authors:  C J Marcus-Sekura; A M Woerner; M Klutch; G V Quinnan
Journal:  Biochim Biophys Acta       Date:  1988-02-28

4.  Expression and processing of human immunodeficiency virus type 1 gag and pol genes by cells infected with a recombinant vaccinia virus.

Authors:  S D Gowda; B S Stein; K S Steimer; E G Engleman
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Biosynthesis and analysis of a genetically engineered HIV-1 reverse transcriptase/endonuclease polyprotein in Escherichia coli.

Authors:  A Leuthardt; S F Le Grice
Journal:  Gene       Date:  1988-08-15       Impact factor: 3.688

6.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

7.  Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus.

Authors:  A Yasuda; J Kimura-Kuroda; M Ogimoto; M Miyamoto; T Sata; T Sato; C Takamura; T Kurata; A Kojima; K Yasui
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Integration is not necessary for expression of human immunodeficiency virus type 1 protein products.

Authors:  M Stevenson; S Haggerty; C A Lamonica; C M Meier; S K Welch; A J Wasiak
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

9.  Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus.

Authors:  E P Lillehoj; F H Salazar; R J Mervis; M G Raum; H W Chan; N Ahmad; S Venkatesan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.

Authors:  M M Lightfoote; J E Coligan; T M Folks; A S Fauci; M A Martin; S Venkatesan
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.